Chabiotech Co.,Ltd.
Research Chabiotech Co.,Ltd. (085660.KQ) on Bullrun: market cap KRW 715.89B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker085660.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 715.89B
- Financial periodQ2 2026
- RevenueKRW 316.43B
- Net incomeKRW 29.26B
- Free cash flow-KRW 40.15B
- Gross margin27.4%
Valuation Snapshot
latest market cap is KRW 715.89B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 715.89B | n/a | n/a | n/a |
Dividend history
About Chabiotech Co.,Ltd.
Chabiotech Co.,Ltd., a bio company, develops cell and gene therapy related to stem and immune cells in South Korea and internationally. The company provides an umbilical cord blood consignment storage for the treatment of incurable diseases; regenerative medicines, immune cell and stem cell storage services, anti-aging, and solutions for incurable diseases; medical wellness programs, comprising fitness, spa, and scupplements;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Chabiotech Co.,Ltd.'s market cap?
Chabiotech Co.,Ltd.'s market capitalization is KRW 715.89B.
What does Chabiotech Co.,Ltd. do?
Chabiotech Co.,Ltd., a bio company, develops cell and gene therapy related to stem and immune cells in South Korea and internationally. The company provides an umbilical cord blood consignment storage for the treatment of incurable diseases; regenerative medicines, immune cell and stem cell storage services, anti-aging, and solutions for incurable diseases; medical wellness programs, comprising fitness, spa, and scupplements; and customized development, production, clinical, and commercialization services to customers with research and development, and clinical experience.